BioCentury | Feb 4, 2016
Distillery Therapeutics

Therapeutics: v-myc myelocytomatosis viral oncogene homolog (MYC; c-Myc); ATM interactor (ATMIN); dynein light chain LC8-type 1 (DYNLL1)

...Cancer INDICATION: B cell lymphoma Mouse studies suggest inhibiting ATMIN or DYNLL1 could help treat MYC-driven...
...growth, the number of B cells in the spleen and bone marrow and levels of DYNLL1...
...marrow compared with normal DYNLL1 expression. Next steps include testing the effect of ATMIN and DYNLL1...
Items per page:
1 - 1 of 1